Azenta, Inc. is a U.S.-based life sciences tools company focused on sample management, cold-chain storage, and related automation and services used by biopharma, research, and clinical customers. Its business is built around protecting, storing, tracking, and moving biological samples and other temperature-sensitive materials, which makes reliability and regulatory compliance central to its value proposition. The company also has exposure to specialty manufacturing and third-party production, including in China, which affects its supply chain and cost structure. Recent filings highlight operational and governance issues, including material weaknesses in internal control over financial reporting and trade/tariff sensitivity across international markets.
5,8 %
45,5 %
−9,4 %
−9,5 %
2.98
2.66
| % | |
|---|---|
| Sample management systems | 30% Automated systems and equipment used to store, retrieve, and manage biological samples. |
| Biostorage and cold-chain services | 25% Temperature-controlled storage and handling services for valuable biological materials. |
| Consumables and tracking products | 15% Tubes, racks, labels, and tracking tools used to identify and manage samples. |
| Life sciences services | 20% Operational services supporting biopharma and research workflows, including sample handling. |
| Specialty equipment and third-party manufacturing | 10% Specialized instruments and outsourced production used in the company’s product portfolio. |
Azenta sells primarily to life sciences and biopharma organizations that need secure, traceable sample storage and...
Buy sample management systems, storage, and services to protect high-value research and clinical samples.
Purchase storage and tracking solutions for long-term sample integrity and lab workflow efficiency.
Use cold-chain and sample handling services to maintain compliance and operational reliability.
Buy across regions where shipping, tariffs, and local sourcing can influence product availability and cost.
Azenta operates as an international business and sells a significant number of products outside the United States...
Azenta’s near-term focus appears centered on stabilizing operations, remediating internal control weaknesses, and...
Reliable financial reporting is necessary to maintain investor confidence, SEC compliance, and operational discipline.
The company depends on third-party manufacturers and service providers, including in China, so continuity and quality are critical.
International sales and cross-border sourcing can be disrupted by tariffs, retaliatory measures, and trade restrictions.
Azenta faces a mix of company-specific and industry-wide risks tied to its supply chain, controls environment, and...
Management disclosed that internal control over financial reporting was not effective, increasing the risk of errors and delayed reporting.
A portion of production and services is outsourced in China, so supplier disruption or forced changes could affect supply and quality.
The company sells many products outside the U.S. and is exposed to tariffs, retaliatory measures, and trade policy changes.
If enacted and implemented, the law could affect sourcing and customer demand for biotechnology equipment and services.
NOVT · Miscellaneous Electrical Machinery, Equipment & Supplies
CYRX · Pharmaceutical Preparations
MLAB · Industrial Instruments For Measurement, Display, and Control
Mesa Laboratories designs and manufactures life sciences tools and critical quality control solutions used in regulated pharmaceutical, healthcare, and medical device applications.
AZTR · Pharmaceutical Preparations
BMRA · In Vitro & In Vivo Diagnostic Substances
COR · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Cencora is a pharmaceutical sourcing and distribution company that sits between drug manufacturers and healthcare providers, moving branded, specialty,…
: 11/08/2026